Corbus Pharmaceuticals Holdings (CRBP) Amortization of Deferred Charges (2013 - 2022)

Corbus Pharmaceuticals Holdings' Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $172734.0 for Q1 2022.

• In Q1 2022, Amortization of Deferred Charges rose 13.37% year-over-year to $172734.0; the TTM figure through Mar 2022 stood at $659789.0 (up 12.92% YoY), while the FY2021 annual figure was $639415.0, up 12.09% from the prior year.
• Amortization of Deferred Charges was $172734.0 for Q1 2022 at Corbus Pharmaceuticals Holdings, up from $167461.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $333865.0 in Q1 2018 to a low of $89179.0 in Q1 2019.
• Historically, Amortization of Deferred Charges has averaged $157634.1 across 5 years, with a median of $145734.0 in 2019.
• The sharpest annual moves came in 2019 and 2020: Amortization of Deferred Charges slumped 73.29% in 2019, then jumped 55.32% in 2020.
• A 5-year view of Amortization of Deferred Charges shows it stood at $333865.0 in 2018, then slumped by 60.53% to $131791.0 in 2019, then advanced by 12.09% to $147723.0 in 2020, then increased by 13.36% to $167461.0 in 2021, then increased by 3.15% to $172734.0 in 2022.
• The last three Amortization of Deferred Charges figures came in at $172734.0 (Q1 2022), $167461.0 (Q4 2021), and $162318.0 (Q3 2021), per Business Quant data.